Hear from an expert about self-collection in a healthcare setting

Be at the forefront of cervical cancer screening with BD Onclarity™ HVP Assay, the first and only FDA-approved HPV assay offering both extended genotyping and self-collection in a healthcare setting.

Latest resources

Discover our latest articles, webinars, press releases and updates in women's health.

ReachMD: Genotype specific persistence: Looking beyond HPV 16
Cervical Cancer | Webinars & Videos
ReachMD: Genotype specific persistence: Looking beyond HPV 16
Modern Healthcare: How is extended genotyping shaping the future of cervical cancer screening?
Cervical Cancer | News & Updates
Modern Healthcare: How is extended genotyping shaping the future of cervical cancer screening?
Molly Broache, Associate Director, Medical Affairs for US IDS discusses the future of cervical cancer screening
Cervical Cancer | News & Updates
Clinical Lab Products: The Future of Cervical Cancer Screening is Here